WallStreetZenWallStreetZen

NASDAQ: CDNA
Caredx Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for CDNA

Based on 2 analysts offering 12 month price targets for Caredx Inc.
Min Forecast
$35.00+92.2%
Avg Forecast
$42.50+133.39%
Max Forecast
$50.00+174.57%

Should I buy or sell CDNA stock?

Based on 2 analysts offering ratings for Caredx Inc.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDNA stock forecasts and price targets.

CDNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Bottom 3%
3
Strong BuyMaintains$35.00+92.20%2022-08-10
Stephens & Co.
Bottom 19%
19
Strong BuyInitiates Coverage On$50.00+174.57%2022-04-25

1 of 1

Forecast return on equity

Is CDNA forecast to generate an efficient return?
Company
-6.39%
Industry
535.43%
Market
110.54%
CDNA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDNA forecast to generate an efficient return on assets?
Company
-5.23%
Industry
11.42%
CDNA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDNA earnings per share forecast

What is CDNA's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.54
Avg 2 year Forecast
-$1.05
Avg 3 year Forecast
-$0.53

CDNA revenue forecast

What is CDNA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$326.0M+3.53%
Avg 2 year Forecast
$365.9M+16.2%
Avg 3 year Forecast
$435.4M+38.3%
CDNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDNA revenue growth forecast

How is CDNA forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
8.88%
Industry
3.87%
Market
8.49%
CDNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDNA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
CDNA$18.21$42.50+133.39%Strong Buy
NRC$39.01N/AN/A
HSKA$74.96$189.67+153.02%Strong Buy
NEO$9.15$24.63+169.13%Buy
FLGT$38.33$86.67+126.11%Strong Buy

Caredx Stock Forecast FAQ

Is Caredx Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDNA) stock is to Strong Buy CDNA stock.

Out of 2 analysts, 2 (100%) are recommending CDNA as a Strong Buy, 0 (0%) are recommending CDNA as a Buy, 0 (0%) are recommending CDNA as a Hold, 0 (0%) are recommending CDNA as a Sell, and 0 (0%) are recommending CDNA as a Strong Sell.

If you're new to stock investing, here's how to buy Caredx stock.

What is CDNA's earnings growth forecast for 2022-2024?

(NASDAQ: CDNA) Caredx's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 14.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.09%.

Caredx's earnings in 2022 is -$69,393,000.On average, 2 Wall Street analysts forecast CDNA's earnings for 2022 to be -$82,325,514, with the lowest CDNA earnings forecast at -$82,325,514, and the highest CDNA earnings forecast at -$82,325,514. On average, 2 Wall Street analysts forecast CDNA's earnings for 2023 to be -$56,131,032, with the lowest CDNA earnings forecast at -$60,407,682, and the highest CDNA earnings forecast at -$51,854,382.

In 2024, CDNA is forecast to generate -$28,332,807 in earnings, with the lowest earnings forecast at -$28,332,807 and the highest earnings forecast at -$28,332,807.

What is CDNA's revenue growth forecast for 2022-2024?

(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 8.88% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.87%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.49%.

Caredx's revenue in 2022 is $314,859,000.On average, 3 Wall Street analysts forecast CDNA's revenue for 2022 to be $17,425,371,125, with the lowest CDNA revenue forecast at $17,373,890,950, and the highest CDNA revenue forecast at $17,524,642,865. On average, 3 Wall Street analysts forecast CDNA's revenue for 2023 to be $19,557,708,855, with the lowest CDNA revenue forecast at $19,116,091,276, and the highest CDNA revenue forecast at $20,044,926,216.

In 2024, CDNA is forecast to generate $23,277,752,927 in revenue, with the lowest revenue forecast at $23,277,752,927 and the highest revenue forecast at $23,277,752,927.

What is CDNA's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: CDNA) forecast ROA is -5.23%, which is lower than the forecast US Diagnostics & Research industry average of 11.42%.

What is CDNA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDNA price target, the average CDNA price target is $42.50, with the highest CDNA stock price forecast at $50.00 and the lowest CDNA stock price forecast at $35.00.

On average, Wall Street analysts predict that Caredx's share price could reach $42.50 by Aug 10, 2023. The average Caredx stock price prediction forecasts a potential upside of 133.39% from the current CDNA share price of $18.21.

What is CDNA's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: CDNA) Caredx's current Earnings Per Share (EPS) is -$1.32. On average, analysts forecast that CDNA's EPS will be -$1.54 for 2022, with the lowest EPS forecast at -$1.54, and the highest EPS forecast at -$1.54. On average, analysts forecast that CDNA's EPS will be -$1.05 for 2023, with the lowest EPS forecast at -$1.13, and the highest EPS forecast at -$0.97. In 2024, CDNA's EPS is forecast to hit -$0.53 (min: -$0.53, max: -$0.53).

What is CDNA's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: CDNA) forecast ROE is -6.39%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.